▼ SELL
10b5-1 Plan
$ Value
$54K
Shares
667
Price
$81
Filed
Sep 9
Insider
Name
Malady Kyle
Title
—
CIK
0001760581
Roles
Director
Transaction Details
Transaction Date
2025-09-05
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,667
Footnotes
On June 6, 2025, Mr. Malady adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Malady. The shares set forth above were sold pursuant to the 10b5-1 Plan. | Included in this number are 5,192 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.
Filing Info
Malady Kyle's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-09 | VZ | A | $2K |
| 2026-04-01 | VZ | A | $0 |
| 2026-03-26 | VZ | A | $2K |
| 2026-02-12 | VZ | A | $2K |
| 2026-02-11 | VZ | A | — |
| 2026-02-11 | VZ | F | $2.8M |
| 2026-02-04 | VZ | A | $0 |
| 2026-01-29 | VZ | A | $2K |
| 2026-01-15 | VZ | A | $2K |
| 2025-12-31 | VZ | A | $2K |
Other Insiders at DXCM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SAYER KEVIN R
Executive Chair
|
— | — | 2026-01-29 |
| Heller Bridgette P | — | $69K | 2026-02-12 |
|
Sylvain Jereme M
EVP, Chief Financal Officer
|
— | — | 2026-01-29 |
|
Leach Jacob Steven
President, CEO, and Director
|
— | — | 2026-01-29 |
|
Stern Sadie
EVP, Chief HR Officer
|
— | — | 2026-01-29 |
|
Brown Michael Jon
EVP, Chief Legal Officer
|
— | $107K | 2026-04-15 |